2Rhee K, Kang K, Kim ], eta[. Intravenous clondine pro longs bupivaeaine spianl anesthesia. Acta Anaesthesiol Scan& 2003, 42(8) : 1001-1005. 被引量：1
3Shukla D, Verma A, Aqarwal A, et al. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to hupivacaine. J Anaesthesiol Ctin Pharmacol, 2011, 27(4):495-499. 被引量：1
4A1-Mustafa MM, Abu Halaweh SA, Aloweidi AS, et al. Effect of dexmedetomidine added to spinal bupivacaine for u- rological procedures. Saudi Med J, 2009, 30(3)..365-370. 被引量：1
5Kaya FN, Yavascaoglu B, Turker G, et al. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth, 2010, 57(1) :39-45. 被引量：1
6Hong JY, Kim WO, Yoon Y, et aL Effects of intravenous dexmedetomidine on low-dose bupivacaine spinal anaesthesia in elderly patients. Aeta Anaesthesiol Scand, 2012, 56(3) :382-387. 被引量：1
7Magalhaes E, Ladeira LC, Govfia CS, et al. Intravenous dexmedetomidine for sedation does not interfere with sensory and motor block duration during spinal anesthesia. Rev Bras Anestesiol,2006, 56(1) .. 1-7. 被引量：1
8A1-Mustafa MM, Badran IZ, Abu-Ali HM, et al. Intrave- nous dexmedetomidine prolongs bupivaeaine spinal analgesia. Middle East J Anesthesiol, 2009, 20 (2) : 225-231. 被引量：1
4Markham A, Faulds D. Ropivaeaine. A review of its pharmacology and therapeutic use in regional anaesthesia. Drugs, 1996,52:429-449. 被引量：1
5Van Kleef JW, Veering BT, Burm AG. Spinal anesthesia with ropivacaine: a double-blind study on the efficacy and safety of 0.5% and 0.75% solutions in patients undergoing minor lower limb surgery. Anesth Analg, 1994,78 : 1125-1130. 被引量：1
6Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand, 1998,42: 685-690. 被引量：1
7Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg, 1996,82 : 636-640. 被引量：1
8McNamee DA, McClelland AM, Scott S, et al. Spinal anaesthesia: comparison of plain ropivacaine 5 mg/ml with bupivacaine 5 mg/ml for major orthopaedic surgery. Br J Anaesth, 2002,89 : 702-706. 被引量：1
9McNamee DA, Parks L, McClelland AM, et al. lntrathecal ropivacaine for total hip arthroplasty: double-blind comparative study with isobaric 7.5 mg/ml and 10 mg/ml solutions. Br J Anaesth, 2001, 87: 743-747. 被引量：1
10Malinovsky JM, Charles F, Kick O, et al. Intrathecal anesthesia: ropivacaine versus bupivacaine. Anesth Analg, 2000, 91: 1457-1460. 被引量：1
5Cho JS,Kim S,Shin S,et al.Effects of Dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation[J].Am J Ther,2014,5(14):12-14. 被引量：1
6Herrmann M,Ebert AD,Galazky I,et al.Neurobehavioral outcome prediction after cardiac surgery:role of neurobehavioral markers of damage to neuronal and glial brain tissue[J].Stroke,2000,31:645-650. 被引量：1
7Plambech MZ,Afshari A.Dexmedetomidine in the pediatric population:a review[J].Minerva Anestesiol,2014,5(14):53-55. 被引量：1
8Abdallab FW,Abrishami A,Brull R.The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia:a systematic review and meta-analysis[J].Anesth Analg,2013,117(1):271-278. 被引量：1
9Paris A,Mantz J,Tonner PH,et al.The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoce-ptor subtype[J].Anesth Analg,2006,102(2):456-461. 被引量：1
10Ma D,Rajakumaraswamy N,Maze M.alpha2-Adrenoceptor agonists:shedding light on neuroprotection[J].Br Med Bull,2005,31 (71):77-92. 被引量：1
